The gastric epithelial cells ribosome-UDP-GalNAc complex is a donor of UDPGalNAc as the substrate for N-acetylgalactosaminyltransferase, which catalyse the transfer of GalNAc residue to the polypeptide, existing on polysomes. It was observed that the deglycosylated porcine mucin and synthetic peptide (PTSSPIST) can be also glycosylated with participation of N-acetylgalactosaminyltransferase and ribosome-UDP-GalNAc complex. The probability of the ribosome-UDP-GalNAc complex as an intermediate in the O-glycosylation is considered.
Glycoprotein biosynthesis, especially its sequential O-glycosylation, has been a matter of investigations for many years. In contrast to N-glycosylation, O-glycosylation does not begin with the transfer of oligosaccharide from a dolichol precursor, but with the addition of a single monosaccharide from the nucleotide substrate to acceptors. In the case of mucintype glycoproteins, GalNAc is transferred to the hydroxyl of some serine or threonine residues of the mucin protein backbone. The polypeptide N-acetylgalactosaminyltransferase family (pp-GalNAc-transferase, EC 2.4.1.41) is involved in the initiation of O-glycosylation. The site of the subcellular compartment where O-glycosylation is initiated is still controversial (ER, proximal Golgi, intermediate ER-Golgi, beyond ER-Golgi in Golgi apparatus) [1] [2] [3] [4] [5] [6] [7] [8] and may depend on the type of pp-GalNAc-transferases involved.
In a previous study we demonstrated the formation of stable complexes between active ribosomes and nucleotide carbohydrates, which have the ability to form the substrates for glycosyltransferases [9] [10] [11] or apomucin preparation), as acceptors in glycosyltransferase reaction in vitro, using UDP-N-acetylgalactosamine-ribosome complex as a carbohydrate donor. In our earlier investigations we demonstrated the formation of Dol-P-P-(GlcNAc) 2 with UDP-GlcNAc-ribosome complex. The oligosaccharide from Dol-P-P-(GlcNAc) 2 was incorporated in vitro into the polypeptide synthesized on polysomes [12] . 14 C]GalNAc (9.2 nmoles), GalNActransferase preparation, 5 mM MnCl 2 and 50 mM imidazole/HCl buffer, pH 7.2, was incubated at 37°C for 30 min in a total volume of 1 ml. The cooled mixture was then centrifuged for 2.5 h at 105 000´g on the sucrose gradient [13] . The translocation of glycosylated polypeptide from A to P site of elongation factor was performed in the following way: the ribosome pellet was suspended in 0.4 ml of a solution containing: 50 mM Tris/HCl, pH 8.0, 2 mM dithiothreitol, 6 mM MgCl 2 , 80 mM NH 4 Cl, 0.2 mM GTP-MgCl 2 then 60 mg of the elongation factor EF-2 was added and incubated for 30 min at 37°C. Then the sample was cooled in an ice bath, mixed with puromycin (1 mmol) and NH 4 Cl (10 mmoles), and the incubation was continued at 37°C for 30 min. The reaction with puromycin was terminated by the addition of cooled 0.1 M sodium acetate solution, pH 5.5. The GalNAc-containing polypeptide released from ribosomes was extracted [16] and its radioactivity was measured in scintillation liquid (Ultima Gold). 
MATERIALS AND METHODS

Materials
Preparation and purification of mucus glycoproteins
Gastric mucus was obtained in a procedure elaborated in our laboratory [17] . Mucin ex- 422 A. Paszkiewicz-Gadek and otherstract (in 6 M urea) was purified (by gel exclusion chromatography) twice on Sepharose CL-2B and on Sephacryl S-500 columns. Both columns were equilibrated and eluted with 6 M urea solution in borate buffer, pH 7. Fractions containing the mucin were identified by the phenol-sulfuric acid method [18] , pooled, dialyzed against water and tested for purity by SDS/PAGE. Deglycosylation of purified mucin. The purified mucin was reduced and S-carboxymethylated according to Thornton et al. [19] , then digested with pronase and glycoprotein fragments were separated on a Sephacryl S-500 column. The deglycosylation was performed in TFMSA/anisole mixture (10 : 1, v/v), according to Raju & Davidson [20] . After oxidation with periodate and b-elimination [21] , the samples were treated as previously described with TFMSA/ anisole.
Purification of UDP-GalNAc : polypeptide N-acetylgalactosaminyltransferase
pp-GalNAc-transferase (EC 2.4.1.41) was isolated from the porcine gastric mucusa according to the procedure previously described [22] . and 30 nmoles of UDP-GalNAc in a final volume of 0.2 ml. Samples were incubated at 37°f or 60 min. The reaction was stopped by the addition of 100 ml of 25 mM EDTA, and the mixture was applied to a column of Dowex 1-X 8 (2 ml), in acetate form. The column was washed with 10 ml of 20 mM sodium acetate [23] . From the 1 ml fractions aliquots (0.5 ml) were taken, mixed with 5 ml of scintillation liquid and submitted for radioactivity counting.
(b) With the use of ribosome-UDPGalNAc complex. This assay mixture was the same as above except UDP-GalNAc was replaced with ribosome-UDP-GalNAc complex prepared as previously described (see Methods). The ribosome-UDP-GalNAc complex (obtained from 2 mg of mucosa ribosomes and 37.2 nmoles UDP-
was suspended in 120 ml of 0.05 M Tris/HCl buffer, pH 7.4; 20 ml of suspension was submitted for counting the radioactivity bound to the ribosomes, the rest of the sample with ribosome-UDP-GalNAc was used for glycosylation reaction under the same conditions as described above in (a). After incubation, EDTA was added to the assay mixture and next applied to a column (0.8 cm´12 cm) of Sephadex G-50 (fine), equilibrated with 0.1 M NaCl containing 0.02% NaN 3 . The column was eluted with 0.1 M NaCl. The 0.5 ml aliquot of each 1 ml fraction was mixed with 5 ml of scintilation liquid and submitted for radioactivity counting. The radiolabeled apomucin or synthetic peptide was eluted in void volume of the column, and the next fractions contained unbound radiolabeled sugar.
RESULTS AND DISCUSSION
In the first step of our experiments we compared the binding of UDP-Gal The results of glycosylation of nascent polypeptide with ribosome-UDP-GalNAc complex, as well as, with UDP-GalNAc as substrates tested with partially purified preparations of pp-GalNAc-transferase are presented in Table 2 . These results show that the greater amount of sugar was incorporated into the nascent peptide in the case of the glycosylation with the complex ribosome-UDP-GalNAc, because UDP-GalNAc content in the complex was much lower than the concentration of free UDP-GalNAc. These results demonstrate that the GalNAc, from the ribosome-UDPGalNAc complex can be transferred onto the nascent polypetide by the pp-GalNActransferase.
The synthetic peptide (PTSSPIST) or free of carbohydrates apomucin preparations were 424 A. Paszkiewicz-Gadek and others 2000 In the control experiments the ribosomes were inactivated at 100°C for 2 min, other conditions as described in Materials and Methods. (Table 3 ). The results show that, chemically synthesized peptide was glycosylated by ribosome-UDPGalNAc complex as a carbohydrate donor to much higher extent as compared to apomucin preparation (Table 3) . This difference in extent of glycosylation depends upon amino-acid composition of the peptide acceptors: the apomucin consists of only 30% of hydroxyl amino acids but peptide PTSSPIST -62.5% [22] . It is very reasonable to suppose, that in vivo, ribosomes can also participate in the O-glycosylation processes. Some authors suggest that the positioning of pp-GalNAc-transferase on, or near the ribosome might promote the efficient glycosylation of Ser/Thr residues, irrespective of amino-acid sequences adjacent to the glycosylated site [24] . It is also reasonable to assume that ribosomes can play an active or passive intermediate role in the early event in mucin O-glycosylation. Ribosomes can accumulate active forms of carbohydrates, forming complex closely located to glycosyltransferases, connected with the bilayer structure of rough endoplasmic reticulum. Cotranslational O-glycosylation seems to be theoretically plausible; singly glycosylated regions of protein can be more extended, created more accessible conformation for the subsequent glycosylation [25] .
Summarizing, it may be suggested that the epithelial ribosome-UDP-GalNAc complex can play an intermediate role in the initiation of the O-glycosylation process of mucin-type glycoproteins.
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